Pain at intrauterine device placement in a Brazilian center
International Journal of Gynecology & Obstetrics · 2026-10 · 175 (1) · 358-364
DOI: 10.1002/ijgo.71026 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Gynecology & Obstetrics, online erschienen am 21.04.2026. Verfasst von Ana Luiza Savi und 4 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, London, UK. Hauptthemen laut MEDLINE: Intrauterine Devices, Procedural Pain. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP).
Abstract (Originalsprache)
Objective
This study explores pain at intrauterine device (IUD) placement in a large Brazilian cohort.
Methods
We undertook a cross‐sectional analysis of health records from individuals aged 18 to 45 years who underwent IUD placements between 2022 and 2024 at the Department of Obstetrics and Gynecology, Universidade Estadual de Campinas Faculty of Medical Sciences, Campinas, Brazil. Insertion pain was measured immediately after the procedure using a 10‐cm visual analogue scale (VAS). Scores were classified as no pain (0), mild pain (1–3), moderate pain (4–6), and severe pain (≥7). Pain relief included analgesics, antispasmodics, non‐steroidal anti‐inflammatory drugs (NSAIDs), and opioids. We used multivariable regression to assess the association between pre‐insertion pain relief and pain during placement.
Results
We evaluated 6974 individuals. Of 7259 fittings analyzed, 228 (3%) occurred with no pain, 1121 (15%) with mild pain, 2003 (28%) with moderate pain, and 3907 (54%) with severe pain (median [interquartile range] pain score of 7.0 [5.0–8.0]). Clinicians provided pain relief in 429 (6%) of insertions (largely antispasmodics and NSAIDs). After adjusting for age and parity, antispasmodics were associated with moderate to severe pain (adjusted odds ratio [aOR] 1.75; 95% confidence interval: 1.15; 2.68).
Conclusion
Our findings suggest that moderate to severe pain was experienced in 5910 (81%) of IUD insertions, in contrast with the 5% estimate in national guidelines. We also found evidence that pre‐insertion antispasmodic medication was associated with higher moderate to severe pain. Our findings emphasize the need to update guidelines to recognize IUD insertion pain and provide options to manage discomfort.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Faculty of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, London, UK.
- Clinical Trials Unit, Department of Medical Statistics, London School of Hygiene and Tropical Medicine, London, UK.
- Department of Obstetrics and Gynecology, Universidade Estadual de Campinas Faculty of Medical Sciences, Campinas, SP, Brazil.
ORCID-Profile: Ana Luiza Savi, Judith Lieber, Cássia Raquel Teatin Juliato, Rachel Scott, Luis Bahamondes
Förderung
- Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)
Zitieren
APA
Savi, A. L., Lieber, J., Raquel Teatin Juliato, C., Scott, R., & Bahamondes, L. (2026). Pain at intrauterine device placement in a Brazilian center. International Journal of Gynecology & Obstetrics, 175(1), 358-364. https://doi.org/10.1002/ijgo.71026
Vancouver
Savi AL, Lieber J, Raquel Teatin Juliato C, Scott R, Bahamondes L. Pain at intrauterine device placement in a Brazilian center. International Journal of Gynecology & Obstetrics. 2026;175(1):358-364. doi:10.1002/ijgo.71026
BibTeX
@article{Savi2026,
author = {Savi, Ana Luiza and Lieber, Judith and Raquel Teatin Juliato, Cássia and Scott, Rachel and Bahamondes, Luis},
title = {Pain at intrauterine device placement in a Brazilian center},
journal = {International Journal of Gynecology & Obstetrics},
year = {2026},
volume = {175},
number = {1},
pages = {358--364},
doi = {10.1002/ijgo.71026}
}
EUVIMED